Topic: Integrating Alcohol and Depression Screenings into Whole-Person Care
Date: Wednesday, May 9, 2018
Time: 3:00 - 4:30 PM ET
Registration required! Register here.
This event was open to beneficiaries, families, healthcare providers, practitioners, partners, and Quality Innovation Network-Quality Improvement Organizations (QIN-QIOs).
Join us for the upcoming National Learning & Action Network (LAN) Event titled, “Integrating Alcohol and Depression Screenings into Whole-Person Care.” This event will include a panel discussion, featuring providers who have integrated behavioral health screenings into their practices. This event will be framed by a patient perspective shared through personal story and in the panel discussion.
- Recognize behavioral health as a factor in healthcare inequity and poor health outcomes in urban medically underserved populations.
- Describe how to incorporate behavioral health and substance misuse screening into the practice workflow.
- Utilize two strategies for initiating a conversation with patients about screening results, enhancing patient engagement, and motivating health behavior change.
- Identify effective community partnerships in achieving whole person care.
Slides & Recorded Presentation:
- Stay tuned for the slides for this event.
- Stay tuned for the recorded presentation.
Meet the Speakers:
Edwin Boudreaux, PhD
University of Massachusetts Medical School
Rachel Hovis, MD
Cherokee Health Systems
Melissa Clarke, MD, CMQ
Medical Home Development Group
- Behavioral Health Bite-sized Learnings
- Centers for Disease Control & Prevention (CDC) Planning and Implementing Screening and Brief Intervention for Risky Alcohol Use: A step-by-step guide for primary care practices
Continuing Education Credit Will Be Offered for Attending the Live Webinar:
The purpose of this session is to prepare healthcare quality improvement professionals to identify and implement effective healthcare strategies by exploring promising practices to implement substance misuse and behavioral health screenings into whole-person care.
We expect that this experience will help participants demonstrate and promote successful delivery of care practices and identify opportunities for improvement, all of which may promote advances in care that impact the Medicare beneficiaries served by the work of the QIO Program.
Method of Participation:
You must participate in the entire activity to receive credit. A statement of credit will be available upon completion of an online evaluation/claimed credit form. The link to the online evaluation will be provided after completion of the activity. If you have questions about this CME/CE activity, please contact AKH Inc. at email@example.com.
CME/CE Credit Provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare, CRW & Associates and Telligen. AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for Physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for 1.5 contact hours (0.15 CEUs). 0077-9999-18-018-L04-P; 0077-9999-18-018-L04-T. Initial Release Date: 5/9/2018
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 1.5 contact hours.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare, CRW & Associates and Telligen.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider Number: 030803.
This activity is approved for 1.5 contact hours which includes 0 hour(s) of pharmacology. Activity ID #21868-3.
AKH Inc., Advancing Knowledge in Healthcare is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dieticians (RDs) and dietetic technicians, registered (DTRs) will receive 1.5 continuing professional education units (CPEU) for completion of this program/material. CDR Accredited Provider #AN008. The focus of this activity is rated Level 2. Learners may submit evaluations of program/materials quality to the CDR at www.cdrnet.org.
Disclosure of Financial Relationships & Commercial Support:
- AKH Inc., CRW & Associates, and Telligen do not have any relevant financial relationships to disclose.
- No commercial support was received for this activity.
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use and Investigational Product:
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.